| 14602 | N | 021759 | 003 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ELOXATIN | SANOFI AVENTIS US | 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 2006-11-17 | Nov 17, 2006 | No | Yes | No | DISCN | SANOFI AVENTIS US LLC | b59c3d08c5fa69b9de176e923a875489938fc16a97e1f2351bcffad8a44b075e |
| 14603 | A | 205379 | 001 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ESOMEPRAZOLE SODIUM | ACCORD HLTHCARE | EQ 40MG BASE/VIAL | AP | ["AP"] | 2015-09-25 | Sep 25, 2015 | No | No | No | RX | ACCORD HEALTHCARE INC | 2d5de49319f737f188ad0eb1688aacbceb913ced7952b5fa3d8925579fe0a693 |
| 14604 | A | 204657 | 001 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ESOMEPRAZOLE SODIUM | AUROBINDO PHARMA LTD | EQ 20MG BASE/VIAL | | [] | 2016-08-10 | Aug 10, 2016 | No | No | No | DISCN | AUROBINDO PHARMA LTD | 192b9e09a8fee7a224bceb1c3175fd891e08bf3c35c14c71c8a0c7ad163f2cf9 |
| 14605 | A | 204657 | 002 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ESOMEPRAZOLE SODIUM | AUROBINDO PHARMA LTD | EQ 40MG BASE/VIAL | AP | ["AP"] | 2016-08-10 | Aug 10, 2016 | No | No | Yes | RX | AUROBINDO PHARMA LTD | 237429abc95921a4ed2d30c7d9f8726114be19eae81141b22e007fda226ee382 |
| 14606 | A | 207181 | 001 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ESOMEPRAZOLE SODIUM | DEVA HOLDING AS | EQ 40MG BASE/VIAL | AP | ["AP"] | 2017-03-06 | Mar 6, 2017 | No | No | No | RX | DEVA HOLDING AS | 5b78e788c36b8c95372bc1c4fbe308a38be22973cae3900bc26ac0722a67e087 |
| 14607 | A | 203349 | 001 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ESOMEPRAZOLE SODIUM | GLAND PHARMA LTD | EQ 20MG BASE/VIAL | AP | ["AP"] | 2020-04-01 | Apr 1, 2020 | No | No | No | RX | GLAND PHARMA LTD | 76fdee0a2f78ddfa3e109c3c76cd45fef3ee4ae4a14c3a3f4c8a20134750fa00 |
| 14608 | A | 203349 | 002 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ESOMEPRAZOLE SODIUM | GLAND PHARMA LTD | EQ 40MG BASE/VIAL | AP | ["AP"] | 2020-04-01 | Apr 1, 2020 | No | No | No | RX | GLAND PHARMA LTD | f02931900f732810944a2a0dafa16c7386f1fab512f2f1437fc60f19a6fbebb8 |
| 14609 | A | 202686 | 001 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ESOMEPRAZOLE SODIUM | MYLAN LABS LTD | EQ 20MG BASE/VIAL | | [] | 2017-05-17 | May 17, 2017 | No | No | No | DISCN | MYLAN LABORATORIES LTD | d9ee03387d3ccd91e15b1fa1207b8094dcf11dc7c665735ea05a6e61e942ec07 |
| 14610 | A | 202686 | 002 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ESOMEPRAZOLE SODIUM | MYLAN LABS LTD | EQ 40MG BASE/VIAL | AP | ["AP"] | 2017-05-17 | May 17, 2017 | No | No | No | RX | MYLAN LABORATORIES LTD | 10de0a9ab09c3a6ab5622c7c7efe532267aeb67233e450c274403f2298b499e9 |
| 14611 | A | 200882 | 001 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ESOMEPRAZOLE SODIUM | SUN PHARMA GLOBAL | EQ 20MG BASE/VIAL | | [] | 2013-03-18 | Mar 18, 2013 | No | No | No | DISCN | SUN PHARMA GLOBAL FZE | b4e6b514ee2d18edece73124e3e75ae2887c3e59c2c54670f0cbff1e7cc061d6 |
| 14612 | A | 200882 | 002 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | ESOMEPRAZOLE SODIUM | SUN PHARMA GLOBAL | EQ 40MG BASE/VIAL | AP | ["AP"] | 2013-03-18 | Mar 18, 2013 | No | No | No | RX | SUN PHARMA GLOBAL FZE | 836cd2c1583da3401b906ae00e24d8945de98d7805b03f40901a21fb100613d7 |
| 14613 | A | 203778 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | 3D IMAGING DRUG | 20-300mCi/ML | AP | ["AP"] | 2015-10-30 | Oct 30, 2015 | No | No | No | RX | 3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC | 4080c2bafb3b3410046fe26aa0486815ce005d523a1b7e4ff9a3ee0f529b1c5b |
| 14614 | A | 203710 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | BIOMEDCL RES FDN | 20-300mCi/ML | AP | ["AP"] | 2015-05-01 | May 1, 2015 | No | No | No | RX | BIOMEDICAL RESEARCH FOUNDATION NORTHWEST LOUISANA | e095fd4ee9f38beae45d02b61dcdad2476b3a0d1d9afb85b8b185de9f6bd6c1c |
| 14615 | A | 203837 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | BIOMEDCL RES FDN | 20-300mCi/ML | AP | ["AP"] | 2015-05-01 | May 1, 2015 | No | No | No | RX | BIOMEDICAL RESEARCH FOUNDATION NORTHWEST LOUISANA | 1257dac498a065ea53a4c18871335358369640f46230cfecd22d54b1287fde79 |
| 14616 | A | 203816 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | BRIGHAM WOMENS | 20-300mCi/ML | AP | ["AP"] | 2014-10-30 | Oct 30, 2014 | No | No | No | RX | BRIGHAM AND WOMENS HOSP | 7568b271e3c965851c53f696da10d0b8e12af2a3f0a0e9d285ef22e837311650 |
| 14617 | A | 203603 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | CARDINAL HEALTH 414 | 20-300mCi/ML | AP | ["AP"] | 2015-11-13 | Nov 13, 2015 | No | No | No | RX | CARDINAL HEALTH 414 LLC CARDINAL HEALTH NUCLEAR PHARMACY SERVICES | 15710b1d1cfacf310f9853b979edecc9c226b52e725d8c93cde19344c2997b9e |
| 14618 | A | 203603 | 002 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | CARDINAL HEALTH 414 | 20-500mCi/ML | AP | ["AP"] | 2018-09-27 | Sep 27, 2018 | No | No | No | RX | CARDINAL HEALTH 414 LLC CARDINAL HEALTH NUCLEAR PHARMACY SERVICES | d94813ba1a26889bb738d19ca6e1dc7fcb8907369014cc52d2fd334b81b590d1 |
| 14619 | A | 204385 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | CHILDRENS HOSP MI | 20-300mCi/ML | AP | ["AP"] | 2014-10-29 | Oct 29, 2014 | No | No | No | RX | CHILDRENS HOSP MICHIGAN | 0f686c784ae31f992108479082cc1b4189919e4a363377c62a7070624f6d3165 |
| 14620 | A | 204525 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | CPDC | 20-300mCi/ML | AP | ["AP"] | 2014-10-29 | Oct 29, 2014 | No | No | No | RX | CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION | 7b1cdd0cec616baddbeb95d4ad38034739ac1d2d0bef4f232243266a7b1f5658 |
| 14621 | A | 204463 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | DECATUR | 20-300mCi/ML | AP | ["AP"] | 2014-10-21 | Oct 21, 2014 | No | No | No | RX | DECATUR MEMORIAL HOSP | 882cde5fc3abdfb42c40fcae96daf374b8e9c5111d825f4597fb816baf6282bf |
| 14622 | A | 203946 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | ESSENTIAL ISOTOPES | 20-300mCi/ML | AP | ["AP"] | 2014-02-05 | Feb 5, 2014 | No | No | No | RX | ESSENTIAL ISOTOPES LLC | a474083bff5ab3036f7faa434aca7f9c4af1b5b0246db087b0fd7facc3adc218 |
| 14623 | N | 021870 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | FEINSTEIN | 20-200mCi/ML | | [] | 2005-08-19 | Aug 19, 2005 | No | Yes | No | DISCN | FEINSTEIN INSTITUTE MEDICAL RESEARCH | 9166ca9417f385f1e570d9b8148898486ad0d62583bddbb1acd805113c0f0959 |
| 14624 | N | 021870 | 002 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | FEINSTEIN | 20-400mCi/ML | AP | ["AP"] | 2008-11-21 | Nov 21, 2008 | No | Yes | Yes | RX | FEINSTEIN INSTITUTE MEDICAL RESEARCH | e0f45edcfa33ba832cd3e5c0130e854bce306430eeabfddfdd3be8004defb556 |
| 14625 | A | 203937 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | HOT SHOTS NM LLC | 4-500mCi/ML | | [] | 2014-10-30 | Oct 30, 2014 | No | No | No | RX | HOT SHOTS NUCLEAR MEDICINE LLC | 99321cab89634d60df0c3802444c3baad924b9a86bf530f22e9a7cef00725cd4 |
| 14626 | A | 203920 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | JUBILANT DRAXIMAGE | 20-300mCi/ML | AP | ["AP"] | 2015-06-23 | Jun 23, 2015 | No | No | No | RX | JUBILANT DRAXIMAGE RADIOPHARMACIES INC | d0218c41af1452f1b4875912408805ec40581070b7995e666c94be80eca4bbba |
| 14627 | A | 204759 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | KETTERING MEDCTR | 4-40mCi/ML | AP | ["AP"] | 2015-10-27 | Oct 27, 2015 | No | No | No | RX | KETTERING MEDCTR | cf281278a1f8c17bca2b08a932f33f37111560abf47f7f40ee3c75f4222705a2 |
| 14628 | A | 203942 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | KREITCHMAN PET CTR | 10-100mCi/ML | AP | ["AP"] | 2016-04-11 | Apr 11, 2016 | No | No | No | RX | KREITCHMAN PET CENTER | 4304960e2e8754bdde46f6b30e0c1a761357c87761e90de25faadb65fe9fa427 |
| 14629 | A | 204333 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | MA GENERAL HOSP | 20-300mCi/ML | AP | ["AP"] | 2014-09-25 | Sep 25, 2014 | No | No | No | RX | MASSACHUSETTS GENERAL HOSP | b7d26b34b604b3d795f2db7f636b76ca92e39a81e03a4d6a895605859a092628 |
| 14630 | A | 203612 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | MCPRF | 20-240mCi/ML | AP | ["AP"] | 2013-08-05 | Aug 5, 2013 | No | No | No | RX | MAYO CLINIC PET RADIOCHEMISTRY FACILITY | 3975ad4d7d43b5d3f5cc100563a0c98542145a84e0475db1ea80ba03e4f206bd |
| 14631 | A | 208679 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | MEM SLOAN-KETTERING | 20-300mCi/ML | AP | ["AP"] | 2016-12-08 | Dec 8, 2016 | No | No | No | RX | MEMORIAL SLOAN-KETTERING CANCER CENTER | d7e492fbf15470e835a575bc09825195b91fcf0ef087766955d4bf6fdd518ea1 |
| 14632 | A | 203904 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | METHODIST HOSP RES | 20-300mCi/ML | AP | ["AP"] | 2015-04-23 | Apr 23, 2015 | No | No | No | RX | THE METHODIST HOSP RESEARCH INSTITUTE | 20a272cfee83b0328762e4d9ee105ab5e16bf3180cc92867e7c373fd8b235a11 |
| 14633 | A | 203736 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | MIDWEST MEDCL | 20-200mCi/ML | | [] | 2015-11-19 | Nov 19, 2015 | No | No | No | DISCN | MIDWEST MEDICAL ISOTOPES LLC CYCLOTRON DIV | 9029144b89802f9ac384a87d1c2b2b23adf36464336b5a5bd9ad25d413ea2171 |
| 14634 | A | 204472 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | MIPS CRF | 20-300mCi/ML | AP | ["AP"] | 2015-09-11 | Sep 11, 2015 | No | No | No | RX | MIPS CYCLOTRON AND RADIOCHEMISTRY FACILITY | f4b8760c1ac79b6773ace134be0c73a4e21f41933dc79e3a6f9f7bdbdeaae451 |
| 14635 | A | 204512 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | NCM USA BRONX LLC | 20-300mCi/ML | AP | ["AP"] | 2015-01-07 | Jan 7, 2015 | No | No | No | RX | NCM USA BRONX LLC | e5c0a2438729318ba8627217b0f0759fb9928de45aae27e59781ac3521ee0942 |
| 14636 | A | 203994 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | NORTHLAND | 4-500mCi/ML | | [] | 2015-02-04 | Feb 4, 2015 | No | No | No | RX | NORTHLAND NUCLEAR MEDICINE LLC | e1e9deb1567d1d07110c807a6ef099908875991c8133f034894602d8b06ea5d0 |
| 14637 | A | 203911 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | NUKEMED | 4-500mCi/ML | | [] | 2015-04-22 | Apr 22, 2015 | No | No | No | RX | NUKEMED INC DBA SPECTRONRX | c3eb3501c92bacd16e6649884fd740e106b2627ceb256f17ad04118ede739bf6 |
| 14638 | A | 079086 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | PETNET | 20-200mCi/ML | AP | ["AP"] | 2011-02-25 | Feb 25, 2011 | No | No | Yes | RX | PETNET SOLUTIONS INC | 6c384a6c8d6b452feead5cf22ef9b2283beca787d532d9a97fc995f4eaa31e87 |
| 14639 | A | 203664 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | PHARMALOGIC HLDGS | 20-200mCi/ML | AP | ["AP"] | 2014-02-04 | Feb 4, 2014 | No | No | No | RX | PHARMALOGIC HOLDINGS CORP | 497128daef54080e86e47cbc78135e7dcc55a39dde4367bcefa239f4d3db35bb |
| 14640 | A | 204546 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | PRECISION NUCLEAR | 20-500mCi/ML | AP | ["AP"] | 2015-04-07 | Apr 7, 2015 | No | No | No | RX | PRECISION NUCLEAR LLC | 5a61d7031e9a6fd3ff48c31a8e688245bae899e9985dacaa99f74bef57f2b588 |
| 14641 | A | 203771 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | QUEEN HAMAMATSU PET | 10-100mCi/ML | AP | ["AP"] | 2015-08-31 | Aug 31, 2015 | No | No | Yes | RX | QUEEN HAMAMATSU PET IMAGING CENTER | d28084522514c964a2d5c27d30443a49d32faec3b8255b76d4e3150ca0263aae |
| 14642 | A | 204264 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | SHERTECH LABS LLC | 20-300mCi/ML | AP | ["AP"] | 2014-12-18 | Dec 18, 2014 | No | No | No | RX | SHERTECH LABORATORIES LLC | c2ed5cccce13bf412743faf6bbd5a81f21615f8e608ee3671cbcf07dc6a42678 |
| 14643 | A | 203591 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | SOFIE | 20-300mCi/ML | AP | ["AP"] | 2015-08-31 | Aug 31, 2015 | No | No | No | RX | SOFIE CO DBA SOFIE (FKA ZEVACOR PHARMA INC) | 8d834face2bfa968fb1f2a6f46e793fad01eecdbfc4bff3ae0b7f49e36268f8e |
| 14644 | A | 203665 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | SOFIE | 20-500mCi/ML | AP | ["AP"] | 2013-02-14 | Feb 14, 2013 | No | No | Yes | RX | SOFIE CO DBA SOFIE | e3188850b83137ebe795ecc76db5919808b6fe345c8a9c24f63853c2acf99562 |
| 14645 | A | 203801 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | TRUSTEES UNIV PA | 20-200mCi/ML | AP | ["AP"] | 2014-10-29 | Oct 29, 2014 | No | No | No | RX | TRUSTEES OF THE UNIV OF PENNSYLVANIA | 5c3785197798647fa7e480b86fed868b4dfcdc829942797491e190a2cd381aef |
| 14646 | A | 203811 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | UCLA BIOMEDICAL | 4-40mCi/ML | AP | ["AP"] | 2013-06-27 | Jun 27, 2013 | No | No | Yes | RX | UCLA BIOMEDICAL CYCLOTRON | bb6aca8da76efdc99667a5a6cd50d9443259533254297ddb449889f8261d1972 |
| 14647 | A | 203902 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | UCSF RODIOPHARM | 20-300mCi/ML | AP | ["AP"] | 2014-05-09 | May 9, 2014 | No | No | No | RX | UCSF RADIOPHARMACEUTICAL FACILITY | 881cf89587b53813a462fc6046311d4eb539d092426bf824c678f07bfbc2a3c1 |
| 14648 | A | 203990 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | UIHC PET IMAGING | 20-300mCi/ML | AP | ["AP"] | 2014-08-06 | Aug 6, 2014 | No | No | No | RX | UNIV IOWA HOSPS AND CLINICS PET IMAGING CENTER | d29553a136f1a96f7895dad88748d98c8cd12409015730455623fb8fba265ffc |
| 14649 | A | 204531 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | UNIV MICHIGAN | 20-300mCi/ML | AP | ["AP"] | 2015-07-17 | Jul 17, 2015 | No | No | No | RX | UNIV MICHIGAN PET RADIOPHARMACEUTICAL PRODUCTION PROGRAM | 217a98921292433a56405db130e7cd43a7eb647e3648c151d354ac87ebc669df |
| 14650 | A | 209341 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | UNIV SOUTHERN CA | 20-300mCi/ML | AP | ["AP"] | 2020-12-16 | Dec 16, 2020 | No | No | No | RX | UNIV SOUTHERN CALIFORNIA DBA USC MOLECULAR IMAGING CENTER | 786ca54c750ac0d1e6f109bf2761665fff98535edc903dcf4b1896a572ebb497 |
| 14651 | A | 203246 | 001 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | FLUDEOXYGLUCOSE F18 | UNIV TX MD ANDERSON | 20-150mCi/ML | | [] | 2014-01-13 | Jan 13, 2014 | No | No | No | RX | UNIV TEXAS MD ANDERSON CANCER CENTER | f616896a9939dd23ffcc03641d3d8ace7ecbd2e8df1d05c7ce3a3c0247d1c933 |